Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?. (February 2017) - Regnier-Gavier, O.; Coliat, P.; Carinato, H.; Burgy, M.; Exinger, D.; Fischbach, C.; Kalish-Weindling, M.; Ferry, R.; Flesch, H.; Bronner, G.; Hemar, P.; Schultz, P.; et al.